Pub Date : 2024-01-01DOI: 10.1016/j.jvsvi.2024.100132
Background
Endoscopic vein harvesting (EVH) is considered the standard of care for coronary bypass procedures given the lower early morbidity from surgical wound complications. However, the use of EVH for lower extremity (LE) bypass remains controversial owing to concerns about decreased graft patency. In 2022, the BEST-CLI Trial (Best Endovascular vs. Best Surgical Therapy in Patients With Critical Limb Ischemia) demonstrated patients undergoing surgical bypass with adequate great saphenous vein quality experienced a lower incidence of major adverse limb events and mortality than those who underwent endovascular repair. Despite these results, wound complications from large harvest site incisions remain a significant barrier preventing surgical bypass as being the preferred initial treatment. To mitigate wound complications, our practice has adopted EVH as the standard approach for harvesting bypass conduit. Here, we report our recent 5-year experience using EVH for LE bypass.
Methods
One hundred sixty-eight LE bypasses with EVH were evaluated from 2017 to 2022. The cohort included 14 vascular surgeons in 8 hospitals. The primary end point was 30-day surgical wound complications. Secondary end points included bypass patency, need for major amputation, 30-day morbidity and mortality, length of operation, and length of hospitalization. Wound complications were measured using Szilagyi's method, with class I characterized by erythema necessitating antibiotics, class II having drainage or superficial dehiscence, and class III threatening graft integrity and requiring surgical intervention.
Results
A total of 168 LE bypasses with EVH were performed on 166 patients. Of these, 65.48% were male with a median age of 68.4 ± 9.7 years. There were no wound complications related to saphenectomy. Surgical site infections occurred in 22 patients (13.10%). Seven patients (4.17%) had class I complications, 12 (7.14%) had class II complications, and 3 (1.79%) had class III complications. Primary patency at 30 days was 96.10% and 86.84% at 1 year). Seven patients (4.17%) required major amputation at 30 days. The 1-year amputation-free survival was 89.39%. The 30-day postoperative stroke, myocardial infarction, and death rates were 0.60%, 0.60%, and 2.38%, respectively. The median operative time was 3.30 ± 1.18 hours. The median length of hospitalization was 3.00 ± 3.56 days.
Conclusions
EVH minimizes saphenectomy wound complications without compromising patency and limb salvage rates. Older studies suggesting lower patency rates after EVH may have been limited by older technology and inexperienced operators. Whether EVH should be the standard of care for LE bypass warrants further investigation.
{"title":"Contemporary outcomes after endoscopic vein harvesting for lower extremity bypass in a multicenter subspecialty practice","authors":"","doi":"10.1016/j.jvsvi.2024.100132","DOIUrl":"10.1016/j.jvsvi.2024.100132","url":null,"abstract":"<div><h3>Background</h3><p>Endoscopic vein harvesting (<em>EVH</em>) is considered the standard of care for coronary bypass procedures given the lower early morbidity from surgical wound complications. However, the use of EVH for lower extremity (<em>LE</em>) bypass remains controversial owing to concerns about decreased graft patency. In 2022, the BEST-CLI Trial (Best Endovascular vs. Best Surgical Therapy in Patients With Critical Limb Ischemia) demonstrated patients undergoing surgical bypass with adequate great saphenous vein quality experienced a lower incidence of major adverse limb events and mortality than those who underwent endovascular repair. Despite these results, wound complications from large harvest site incisions remain a significant barrier preventing surgical bypass as being the preferred initial treatment. To mitigate wound complications, our practice has adopted EVH as the standard approach for harvesting bypass conduit. Here, we report our recent 5-year experience using EVH for LE bypass.</p></div><div><h3>Methods</h3><p>One hundred sixty-eight LE bypasses with EVH were evaluated from 2017 to 2022. The cohort included 14 vascular surgeons in 8 hospitals. The primary end point was 30-day surgical wound complications. Secondary end points included bypass patency, need for major amputation, 30-day morbidity and mortality, length of operation, and length of hospitalization. Wound complications were measured using Szilagyi's method, with class I characterized by erythema necessitating antibiotics, class II having drainage or superficial dehiscence, and class III threatening graft integrity and requiring surgical intervention.</p></div><div><h3>Results</h3><p>A total of 168 LE bypasses with EVH were performed on 166 patients. Of these, 65.48% were male with a median age of 68.4 ± 9.7 years. There were no wound complications related to saphenectomy. Surgical site infections occurred in 22 patients (13.10%). Seven patients (4.17%) had class I complications, 12 (7.14%) had class II complications, and 3 (1.79%) had class III complications. Primary patency at 30 days was 96.10% and 86.84% at 1 year). Seven patients (4.17%) required major amputation at 30 days. The 1-year amputation-free survival was 89.39%. The 30-day postoperative stroke, myocardial infarction, and death rates were 0.60%, 0.60%, and 2.38%, respectively. The median operative time was 3.30 ± 1.18 hours. The median length of hospitalization was 3.00 ± 3.56 days.</p></div><div><h3>Conclusions</h3><p>EVH minimizes saphenectomy wound complications without compromising patency and limb salvage rates. Older studies suggesting lower patency rates after EVH may have been limited by older technology and inexperienced operators. Whether EVH should be the standard of care for LE bypass warrants further investigation.</p></div>","PeriodicalId":74034,"journal":{"name":"JVS-vascular insights","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2949912724000801/pdfft?md5=15d8c33febd77596c70935bc6bdc05db&pid=1-s2.0-S2949912724000801-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142171979","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-01-01DOI: 10.1016/j.jvsvi.2024.100121
Objective
Traditional views on carotid artery atherosclerosis have largely focused on the degree of stenosis as a predictor for embolic stroke. However, recent evidence highlights the significance of nonstenotic, vulnerable plaques in stroke pathophysiology. This article synthesizes current knowledge on the epidemiology, pathophysiology, and potential treatments of nonstenotic carotid plaques.
Methods
Google Scholar, PubMed, and Scopus were used to search for articles regarding “nonstenotic carotid plaques,” “embolic stroke of unknown source,” “cryptogenic stroke,” and “high-risk carotid imaging findings.” Here we conduct a narrative review of recent literature, focusing on studies published over the past decade, to understand the role of nonstenotic carotid plaques in ischemic strokes, particularly those classified as embolic strokes of unknown source. We present a representative case demonstrating these features.
Results
Nonstenotic plaques are increasingly recognized in patients with embolic strokes of unknown source, with vulnerable characteristics more prevalent on the symptomatic side. There is a higher risk of recurrent stroke in patients with these plaques, prompting reconsideration of therapeutic approaches, including the potential usefulness of carotid endarterectomy and stenting in certain cases.
Conclusions
The growing body of evidence on nonstenotic carotid plaques challenges existing paradigms in stroke management.
{"title":"Nonstenotic symptomatic internal carotid artery plaques: Epidemiology, pathophysiology, and treatment","authors":"","doi":"10.1016/j.jvsvi.2024.100121","DOIUrl":"10.1016/j.jvsvi.2024.100121","url":null,"abstract":"<div><h3>Objective</h3><p>Traditional views on carotid artery atherosclerosis have largely focused on the degree of stenosis as a predictor for embolic stroke. However, recent evidence highlights the significance of nonstenotic, vulnerable plaques in stroke pathophysiology. This article synthesizes current knowledge on the epidemiology, pathophysiology, and potential treatments of nonstenotic carotid plaques.</p></div><div><h3>Methods</h3><p>Google Scholar, PubMed, and Scopus were used to search for articles regarding “nonstenotic carotid plaques,” “embolic stroke of unknown source,” “cryptogenic stroke,” and “high-risk carotid imaging findings.” Here we conduct a narrative review of recent literature, focusing on studies published over the past decade, to understand the role of nonstenotic carotid plaques in ischemic strokes, particularly those classified as embolic strokes of unknown source. We present a representative case demonstrating these features.</p></div><div><h3>Results</h3><p>Nonstenotic plaques are increasingly recognized in patients with embolic strokes of unknown source, with vulnerable characteristics more prevalent on the symptomatic side. There is a higher risk of recurrent stroke in patients with these plaques, prompting reconsideration of therapeutic approaches, including the potential usefulness of carotid endarterectomy and stenting in certain cases.</p></div><div><h3>Conclusions</h3><p>The growing body of evidence on nonstenotic carotid plaques challenges existing paradigms in stroke management.</p></div>","PeriodicalId":74034,"journal":{"name":"JVS-vascular insights","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2949912724000692/pdfft?md5=c9ede8370748a5967fab6ffdb5f4c285&pid=1-s2.0-S2949912724000692-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142129467","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-01-01DOI: 10.1016/j.jvsvi.2024.100116
{"title":"The past, present, and future of feedback in medical education","authors":"","doi":"10.1016/j.jvsvi.2024.100116","DOIUrl":"10.1016/j.jvsvi.2024.100116","url":null,"abstract":"","PeriodicalId":74034,"journal":{"name":"JVS-vascular insights","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2949912724000643/pdfft?md5=eab33eadf14ec039354fe2605af77738&pid=1-s2.0-S2949912724000643-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141709558","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-01-01DOI: 10.1016/j.jvsvi.2024.100122
{"title":"Adapting to declining open surgical volume in vascular surgery","authors":"","doi":"10.1016/j.jvsvi.2024.100122","DOIUrl":"10.1016/j.jvsvi.2024.100122","url":null,"abstract":"","PeriodicalId":74034,"journal":{"name":"JVS-vascular insights","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2949912724000709/pdfft?md5=435a1a93ebd9b74525c6fbf0f2fe29e1&pid=1-s2.0-S2949912724000709-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141849692","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-01-01DOI: 10.1016/j.jvsvi.2024.100127
Lack of diversity in biomedical science and clinical medicine is well documented but persists even despite evidence to suggest that scientific discovery, generalizability of treatments, access to equitable health care, and clinical outcomes are limited without a diverse workforce. The science, technology, engineering, and mathematics workforce is severely under-represented in terms of females, under-represented minorities, and people with disabilities. Common barriers to entering science and medical fields include lack of mentorship, overt discrimination, compensation differences, and lack of early exposure. However, the lack of diversity does not end with the workforce and persists within clinical trials and databases leading to differences in health care accessibility and outcomes. Although there have been strides taken over the past several decades in improving diversity among medicine, research, and specifically vascular surgery science, the work is clearly not yet done. By increasing awareness of the problem of lack of diversity within vascular surgery, the future is bright regarding not only the vascular surgery workforce but also the patients treated within the health care system.
{"title":"Promoting diversity and inclusion in vascular surgery science: challenges and opportunities","authors":"","doi":"10.1016/j.jvsvi.2024.100127","DOIUrl":"10.1016/j.jvsvi.2024.100127","url":null,"abstract":"<div><p>Lack of diversity in biomedical science and clinical medicine is well documented but persists even despite evidence to suggest that scientific discovery, generalizability of treatments, access to equitable health care, and clinical outcomes are limited without a diverse workforce. The science, technology, engineering, and mathematics workforce is severely under-represented in terms of females, under-represented minorities, and people with disabilities. Common barriers to entering science and medical fields include lack of mentorship, overt discrimination, compensation differences, and lack of early exposure. However, the lack of diversity does not end with the workforce and persists within clinical trials and databases leading to differences in health care accessibility and outcomes. Although there have been strides taken over the past several decades in improving diversity among medicine, research, and specifically vascular surgery science, the work is clearly not yet done. By increasing awareness of the problem of lack of diversity within vascular surgery, the future is bright regarding not only the vascular surgery workforce but also the patients treated within the health care system.</p></div>","PeriodicalId":74034,"journal":{"name":"JVS-vascular insights","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2949912724000758/pdfft?md5=7935182cf54bea851034d81fcd179062&pid=1-s2.0-S2949912724000758-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142270513","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-01-01DOI: 10.1016/j.jvsvi.2024.100106
Background
Burnout affects the quality of patient care by increasing the probability of medical errors and decreasing patient satisfaction. An environmental approach has been implemented to address burnout, recognizing that burnout can be triggered by conditions in the workplace, particularly when work bullying occurs repeatedly over an extended period of time and undermines an individual’s character, integrity, or dignity. Multiple studies have examined the prevalence of burnout among vascular surgeons, with estimates ranging from 34% to 41%. However, work bullying has not been studied as a cause of burnout. This study aimed to determine the relationship between work bullying and increased burnout rates among Mexican vascular surgeons.
Methods
This study consisted of a survey of Mexican vascular surgeons currently in practice. The Maslach Burnout Inventory was used to assess burnout, and the modified Leymann Inventory of Psychological Terrorism-60 was used to assess work bullying tactics. The study additionally aimed to identify vulnerable groups that are more susceptible to burnout, such as gender, age, working long hours, and type of practice, in order to determine if they are equally affected by work bullying.
Results
Burnout symptoms were found in 41% of the 142 completed surveys examined, with emotional exhaustion being the most common component. Positive work bullying strategies affected 32% of the population. The study demonstrated a strong association between burnout and work bullying, with work bullying victims having a greater risk of developing burnout (odds ratio = 2.9; 95% confidence interval [1.41; 5.98]; P < .01). In addition, female gender, younger generation, working more than 60 hours per week, and practicing in the public sector were also related to a greater prevalence of burnout and work bullying.
Conclusions
This study found a significant correlation between burnout and work bullying among Mexican vascular surgeons. These findings suggest that preventative measures against work bullying may reduce the incidence of burnout among this population.
{"title":"Relationship of work bullying and burnout among vascular surgeons","authors":"","doi":"10.1016/j.jvsvi.2024.100106","DOIUrl":"10.1016/j.jvsvi.2024.100106","url":null,"abstract":"<div><h3>Background</h3><p>Burnout affects the quality of patient care by increasing the probability of medical errors and decreasing patient satisfaction. An environmental approach has been implemented to address burnout, recognizing that burnout can be triggered by conditions in the workplace, particularly when work bullying occurs repeatedly over an extended period of time and undermines an individual’s character, integrity, or dignity. Multiple studies have examined the prevalence of burnout among vascular surgeons, with estimates ranging from 34% to 41%. However, work bullying has not been studied as a cause of burnout. This study aimed to determine the relationship between work bullying and increased burnout rates among Mexican vascular surgeons.</p></div><div><h3>Methods</h3><p>This study consisted of a survey of Mexican vascular surgeons currently in practice. The Maslach Burnout Inventory was used to assess burnout, and the modified Leymann Inventory of Psychological Terrorism-60 was used to assess work bullying tactics. The study additionally aimed to identify vulnerable groups that are more susceptible to burnout, such as gender, age, working long hours, and type of practice, in order to determine if they are equally affected by work bullying.</p></div><div><h3>Results</h3><p>Burnout symptoms were found in 41% of the 142 completed surveys examined, with emotional exhaustion being the most common component. Positive work bullying strategies affected 32% of the population. The study demonstrated a strong association between burnout and work bullying, with work bullying victims having a greater risk of developing burnout (odds ratio = 2.9; 95% confidence interval [1.41; 5.98]; <em>P</em> < .01). In addition, female gender, younger generation, working more than 60 hours per week, and practicing in the public sector were also related to a greater prevalence of burnout and work bullying.</p></div><div><h3>Conclusions</h3><p>This study found a significant correlation between burnout and work bullying among Mexican vascular surgeons. These findings suggest that preventative measures against work bullying may reduce the incidence of burnout among this population.</p></div>","PeriodicalId":74034,"journal":{"name":"JVS-vascular insights","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2949912724000540/pdfft?md5=a18cd2d712f807cae8e1f68bf5122a78&pid=1-s2.0-S2949912724000540-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141279384","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-01-01DOI: 10.1016/j.jvsvi.2024.100099
Becoming a vascular surgeon is a long and well-defined process that results in the formation of a capable and competent surgeon that cares for patients with vascular disease in different practice settings. However, the process to find that first job or when considering a job change is not formally discussed. The aim of this paper is to provide the surgeon with a comprehensive framework to help define the ideal position, know what factors to assess, and how to go through the process from application to contract negotiation, to starting the job. Finally, if the surgeon is considering a change, this same framework can be applied, and additional considerations are also discussed.
{"title":"Appraising and finding the right practice model in vascular surgery for a first or subsequent position","authors":"","doi":"10.1016/j.jvsvi.2024.100099","DOIUrl":"10.1016/j.jvsvi.2024.100099","url":null,"abstract":"<div><div>Becoming a vascular surgeon is a long and well-defined process that results in the formation of a capable and competent surgeon that cares for patients with vascular disease in different practice settings. However, the process to find that first job or when considering a job change is not formally discussed. The aim of this paper is to provide the surgeon with a comprehensive framework to help define the ideal position, know what factors to assess, and how to go through the process from application to contract negotiation, to starting the job. Finally, if the surgeon is considering a change, this same framework can be applied, and additional considerations are also discussed.</div></div>","PeriodicalId":74034,"journal":{"name":"JVS-vascular insights","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141414149","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-01-01DOI: 10.1016/j.jvsvi.2024.100058
Mira T. Tanenbaum MD, Andres V. Figueroa MD, Jose Eduardo Costa Filho MD, Marilisa S. Gonzalez MD, Mirza S. Baig MD, Melissa L. Kirkwood MD, Carlos H. Timaran MD
Background
Radiation exposure is a known risk to both patients and providers during endovascular aortic aneurysm repair (EVAR). Complex EVAR procedures, such as fenestrated and branched EVAR, inherently involve longer fluoroscopy times and increased radiation doses. While adhering to the as low as reasonably achievable principles and ensuring appropriate personal protective equipment for all operating room staff remains essential, the use of intraoperative techniques and adjuncts to decrease radiation specifically during complex EVAR is necessary. This review aims to summarize intraoperative radiation reduction techniques to provide valuable insights to vascular surgeons and interventional proceduralists to enhance radiation safety during complex EVAR.
Methods
This review focused on intraoperative techniques and adjuncts that have been used to decrease intraoperative radiation exposure to patients and operators. Published and presented preclinical results, prospective and retrospective study data, and future directions are presented.
Results
We highlight several intraoperative adjuncts and techniques for reducing radiation exposure during complex EVAR including image fusion, digital zooming, intravascular ultrasound examination, Fiber Optic RealShape (FORS) technology, and robotic navigation systems. Short-term outcomes suggest that these techniques are safe, feasible, and effective and decrease radiation exposure to both patients and operators.
Conclusions
Decreasing radiation exposure during complex EVAR remains of critical importance. The presented techniques offer promising avenues for significantly decreasing radiation exposure to both patients and providers while maintaining procedural efficacy during complex EVAR.
{"title":"A narrative review of intraoperative adjuncts and techniques to minimize radiation during complex endovascular aneurysm repair","authors":"Mira T. Tanenbaum MD, Andres V. Figueroa MD, Jose Eduardo Costa Filho MD, Marilisa S. Gonzalez MD, Mirza S. Baig MD, Melissa L. Kirkwood MD, Carlos H. Timaran MD","doi":"10.1016/j.jvsvi.2024.100058","DOIUrl":"10.1016/j.jvsvi.2024.100058","url":null,"abstract":"<div><h3>Background</h3><p>Radiation exposure is a known risk to both patients and providers during endovascular aortic aneurysm repair (EVAR). Complex EVAR procedures, such as fenestrated and branched EVAR, inherently involve longer fluoroscopy times and increased radiation doses. While adhering to the as low as reasonably achievable principles and ensuring appropriate personal protective equipment for all operating room staff remains essential, the use of intraoperative techniques and adjuncts to decrease radiation specifically during complex EVAR is necessary. This review aims to summarize intraoperative radiation reduction techniques to provide valuable insights to vascular surgeons and interventional proceduralists to enhance radiation safety during complex EVAR.</p></div><div><h3>Methods</h3><p>This review focused on intraoperative techniques and adjuncts that have been used to decrease intraoperative radiation exposure to patients and operators. Published and presented preclinical results, prospective and retrospective study data, and future directions are presented.</p></div><div><h3>Results</h3><p>We highlight several intraoperative adjuncts and techniques for reducing radiation exposure during complex EVAR including image fusion, digital zooming, intravascular ultrasound examination, Fiber Optic RealShape (FORS) technology, and robotic navigation systems. Short-term outcomes suggest that these techniques are safe, feasible, and effective and decrease radiation exposure to both patients and operators.</p></div><div><h3>Conclusions</h3><p>Decreasing radiation exposure during complex EVAR remains of critical importance. The presented techniques offer promising avenues for significantly decreasing radiation exposure to both patients and providers while maintaining procedural efficacy during complex EVAR.</p></div>","PeriodicalId":74034,"journal":{"name":"JVS-vascular insights","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2949912724000060/pdfft?md5=dfe391d7adfdd9aad1a40a3289058eb1&pid=1-s2.0-S2949912724000060-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139966559","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-01-01DOI: 10.1016/j.jvsvi.2024.100069
Paarth Jain BS , Jeremy Zack BS , Lauren E. Schlegel MD , Eva Varotsis BS , Robert Pugliese PharmD , Michael Nooromid MD , Babak Abai MD
Objective
Three-dimensional (3D)-printed endovascular models can be an accessible alternative to expensive, state-of-the-art endovascular simulators but currently lack the rigorous validation needed to be dependable educational tools. This study describes the manufacture of a 3D-printed endovascular model of an aorta and determines the construct validity and preliminary content and face validity of the model.
Methods
A 3D-printed aorta was created using segmented data from a patient computerized tomography scan and a FormLabs 3B 3D printer with FormLabs Clear resin. Participants were asked to perform two tasks from a femoral access point: catheterize the contralateral common iliac artery and the superior mesenteric artery. Participants were assessed for task completion, technique, and time. Performance was compared between levels of education (medical student vs lower-year resident vs upper-year resident vs attending) and levels of endovascular experience (<5 procedures vs 6-20 procedures vs 21-100 procedures vs >100 procedures). Users completed questionnaires assessing the face and content validity of the simulator after their participation.
Results
48 participants were recruited (12 medical students, 19 lower-year residents, 13 upper-year residents, and 4 attendings). Of these, 26 participants had performed <5 procedures, 10 had performed 6 to 20 procedures, 7 had performed 21 to 100 procedures, and 5 had performed >100 real-world procedures. Neither education level nor experience level correlated with task completion. Increasing levels of training progressively increased rates of correct technique for both tasks combined (8% vs 21% vs 46% vs 75%, P = .032) and decreased cumulative time (307.3 vs 252.2 vs 185.8 vs 139 seconds, P = .005). Similarly, increased levels of experience progressively increased rates of correct technique for both tasks combined (7% vs 50% vs 71% vs 80%, for increasingly experienced groups, P < .001) and decreased cumulative completion times (276 vs 237 vs 187 vs 113 seconds, P = .003) for both tasks. Multivariate analysis showed that training level was not a predictor for time taken to complete any task, while experience level was a predictor for superior mesenteric artery cannulation time (P < .02). Participants rated the model as having somewhat realistic haptics, dissimilar “look and feel” to the operating room, and strongly believed that the model was valuable for practicing endovascular surgery.
Conclusions
These findings verify the construct validity of this endovascular simulator, as those with the most real-world experience used a correct technique more often and completed the tasks the fastest. Survey results supported the content validity of the model. Basic 3D-printed endovascular models should be considered as an affordable, readily accessible adjunct to su
目的三维(3D)打印的血管内模型可以替代昂贵的、最先进的血管内模拟器,但目前缺乏成为可靠的教育工具所需的严格验证。本研究描述了主动脉三维打印血管内模型的制作过程,并确定了模型的结构效度、初步内容效度和表面效度。方法利用患者计算机断层扫描的分段数据和使用 FormLabs Clear 树脂的 FormLabs 3B 三维打印机制作了主动脉三维打印模型。要求参与者从股骨入路点完成两项任务:导管插入对侧髂总动脉和肠系膜上动脉。对参与者的任务完成情况、技术和时间进行评估。对不同教育水平(医学生 vs 低年级住院医师 vs 高年级住院医师 vs 主治医师)和血管内治疗经验水平(5 例手术 vs 6-20 例手术 vs 21-100 例手术 vs 100 例手术)之间的表现进行了比较。结果共招募了 48 名参与者(12 名医学生、19 名低年级住院医师、13 名高年级住院医师和 4 名主治医师)。其中,26 人进行过 5 次手术,10 人进行过 6 至 20 次手术,7 人进行过 21 至 100 次手术,5 人进行过 100 次实际手术。教育水平和经验水平都与任务完成情况无关。培训水平的提高会逐渐增加两项任务的技术正确率(8% vs 21% vs 46% vs 75%,P = .032),并减少累计时间(307.3 vs 252.2 vs 185.8 vs 139 秒,P = .005)。同样,经验水平的提高会逐渐增加两项任务的技术正确率(经验越丰富的组别,正确率越高,分别为 7% vs 50% vs 71% vs 80%,P = 0.001),并减少两项任务的累计完成时间(276 vs 237 vs 187 vs 113 秒,P = 0.003)。多变量分析表明,培训水平并不能预测完成任何任务所需的时间,而经验水平则能预测肠系膜上动脉插管时间(P < .02)。参与者认为该模型的触觉有些逼真,"外观和感觉 "与手术室不同,并坚信该模型对练习血管内手术很有价值。调查结果支持了模型的内容效度。基本的 3D 打印血管内模型应被视为一种经济实惠、易于获取的外科教育辅助工具。
{"title":"Validating a 3D-printed endovascular simulator for use in training surgical residents","authors":"Paarth Jain BS , Jeremy Zack BS , Lauren E. Schlegel MD , Eva Varotsis BS , Robert Pugliese PharmD , Michael Nooromid MD , Babak Abai MD","doi":"10.1016/j.jvsvi.2024.100069","DOIUrl":"10.1016/j.jvsvi.2024.100069","url":null,"abstract":"<div><h3>Objective</h3><p>Three-dimensional (3D)-printed endovascular models can be an accessible alternative to expensive, state-of-the-art endovascular simulators but currently lack the rigorous validation needed to be dependable educational tools. This study describes the manufacture of a 3D-printed endovascular model of an aorta and determines the construct validity and preliminary content and face validity of the model.</p></div><div><h3>Methods</h3><p>A 3D-printed aorta was created using segmented data from a patient computerized tomography scan and a FormLabs 3B 3D printer with FormLabs Clear resin. Participants were asked to perform two tasks from a femoral access point: catheterize the contralateral common iliac artery and the superior mesenteric artery. Participants were assessed for task completion, technique, and time. Performance was compared between levels of education (medical student vs lower-year resident vs upper-year resident vs attending) and levels of endovascular experience (<5 procedures vs 6-20 procedures vs 21-100 procedures vs >100 procedures). Users completed questionnaires assessing the face and content validity of the simulator after their participation.</p></div><div><h3>Results</h3><p>48 participants were recruited (12 medical students, 19 lower-year residents, 13 upper-year residents, and 4 attendings). Of these, 26 participants had performed <5 procedures, 10 had performed 6 to 20 procedures, 7 had performed 21 to 100 procedures, and 5 had performed >100 real-world procedures. Neither education level nor experience level correlated with task completion. Increasing levels of training progressively increased rates of correct technique for both tasks combined (8% vs 21% vs 46% vs 75%, <em>P</em> = .032) and decreased cumulative time (307.3 vs 252.2 vs 185.8 vs 139 seconds, <em>P</em> = .005). Similarly, increased levels of experience progressively increased rates of correct technique for both tasks combined (7% vs 50% vs 71% vs 80%, for increasingly experienced groups, <em>P</em> < .001) and decreased cumulative completion times (276 vs 237 vs 187 vs 113 seconds, <em>P</em> = .003) for both tasks. Multivariate analysis showed that training level was not a predictor for time taken to complete any task, while experience level was a predictor for superior mesenteric artery cannulation time (<em>P</em> < .02). Participants rated the model as having somewhat realistic haptics, dissimilar “look and feel” to the operating room, and strongly believed that the model was valuable for practicing endovascular surgery.</p></div><div><h3>Conclusions</h3><p>These findings verify the construct validity of this endovascular simulator, as those with the most real-world experience used a correct technique more often and completed the tasks the fastest. Survey results supported the content validity of the model. Basic 3D-printed endovascular models should be considered as an affordable, readily accessible adjunct to su","PeriodicalId":74034,"journal":{"name":"JVS-vascular insights","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2949912724000175/pdfft?md5=3a018a438cd57b5cbfd54cb24696a798&pid=1-s2.0-S2949912724000175-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140268151","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-01-01DOI: 10.1016/j.jvsvi.2024.100077
Valentyna Kostiuk BA , Carly Thaxton MD , Sarah A. Loh MD, MS , Jonathan A. Cardella MD , Alan Dardik MD, PhD , Britt H. Tonnessen MD
Female vascular surgeons constitute 15% of the workforce. Despite an increased pipeline of female vascular surgeons, representation in leadership positions nationally has not maintained pace. We hypothesized that female vascular surgeons are underrepresented as leaders of clinical trials in the United States for several vascular conditions germane to our specialty. Clinical trials registered in the United States were reviewed using the ClinicalTrials.gov website for several index vascular conditions: abdominal aortic aneurysm, carotid artery disease, hemodialysis access, venous thrombectomy and stenting, and peripheral arterial disease. The specialty and presenting gender of national and site principal investigators were recorded. The gender distribution was compared for trials led by vascular surgeons and nonvascular surgeon physicians. A subgroup analysis was performed for solo and group investigators, intervention types, sponsorship sources, and professional affiliation. Temporal trends were examined to evaluate the relationship between the duration of board certification and clinical trial leadership involvement. For all conditions, female vascular surgeons represent 10.3% and 7.8% of national and site principal investigators, respectively. A significantly lower proportion of female investigators were included in national vascular surgeon-led trials compared with nonvascular surgeon-led trials (10.3% vs 19.9%; P = .006). However, site investigators had a lower, but similar, proportion of women in both groups (7.8% vs 7.9%; P = .89). A significantly lower proportion of female vascular surgeons led clinical trials focused on interventions vs noninterventions (6% vs 11%; P = .02). There was a trend toward fewer female vascular surgeons conducting industry-sponsored trials for group (8% vs 11%; P = .3) and solo (5% vs 12%; P = .1) investigator-led trials. A similar proportion of female investigators had both academic and nonacademic affiliations (15% vs 16%; P = .83). Of 109 individual vascular surgeon investigators who were board certified between 1983 and 2003, 6 were women (5.5%) compared with 24 women (28.6%) of 84 investigators who had received board certification between 2004 and 2023. Finally, female vascular surgeon investigators started leading clinical trials sooner after board certification compared with male investigators (mean, 5.5 years vs 10.9 years; P = .0009). The representation of female leaders in vascular clinical trials lags behind that of male leaders, although this trend has improved over time. However, a percentage of women in vascular surgery are successful in leading clinical trials early in their career, suggesting the importance of strong sponsorship and allyship. Furthermore, it is a call to action to our leaders and our industry partners to “lift the curtain” on the pathway to clinical trial leadership.
女性血管外科医生占从业人员总数的 15%。尽管女性血管外科医生的人数在不断增加,但在全国范围内担任领导职务的人数却没有跟上步伐。我们假设,在美国,女性血管外科医生在与本专业相关的几种血管疾病的临床试验中担任领导职务的人数不足。我们使用ClinicalTrials.gov网站对在美国注册的临床试验进行了审查,这些临床试验涉及几种指数血管疾病:腹主动脉瘤、颈动脉疾病、血液透析通路、静脉血栓切除术和支架植入术以及外周动脉疾病。记录了国家和研究机构主要研究人员的专业和性别。比较了由血管外科医生和非血管外科医生领导的试验的性别分布情况。对单独和集体研究者、干预类型、赞助来源和专业隶属关系进行了分组分析。对时间趋势进行了研究,以评估获得委员会认证的时间与参与临床试验领导工作之间的关系。在所有情况下,女性血管外科医生分别占全国和研究机构主要研究者的 10.3% 和 7.8%。与非血管外科医生领导的试验相比,女性研究者参与国家血管外科医生领导的试验的比例明显较低(10.3% vs 19.9%;P = .006)。然而,在两组试验中,现场研究人员中女性所占比例较低,但相近(7.8% vs 7.9%; P = .89)。女性血管外科医生领导的干预性临床试验与非干预性临床试验的比例明显较低(6% vs 11%; P = .02)。在研究者领导的集体试验(8% vs 11%;P = .3)和单独试验(5% vs 12%;P = .1)中,开展行业赞助试验的女性血管外科医生呈减少趋势。同时拥有学术和非学术背景的女性研究者比例相似(15% vs 16%; P = .83)。在1983年至2003年间获得委员会认证的109名血管外科医生研究人员中,有6名女性(5.5%),而在2004年至2023年间获得委员会认证的84名研究人员中,有24名女性(28.6%)。最后,与男性研究人员相比,女性血管外科医生研究人员在获得委员会认证后更早开始领导临床试验(平均 5.5 年 vs 10.9 年;P = 0.0009)。女性领导者在血管临床试验中的代表性落后于男性领导者,尽管随着时间的推移,这一趋势有所改善。不过,在血管外科领域,有一定比例的女性在其职业生涯早期就成功领导了临床试验,这表明强有力的赞助和同盟关系非常重要。此外,该报告还呼吁我们的领导者和行业合作伙伴采取行动,"揭开 "通往临床试验领导者之路的 "帷幕"。
{"title":"Representation of female vascular surgeons in national clinical trial leadership: analysis of trends over 20 years","authors":"Valentyna Kostiuk BA , Carly Thaxton MD , Sarah A. Loh MD, MS , Jonathan A. Cardella MD , Alan Dardik MD, PhD , Britt H. Tonnessen MD","doi":"10.1016/j.jvsvi.2024.100077","DOIUrl":"10.1016/j.jvsvi.2024.100077","url":null,"abstract":"<div><p>Female vascular surgeons constitute 15% of the workforce. Despite an increased pipeline of female vascular surgeons, representation in leadership positions nationally has not maintained pace. We hypothesized that female vascular surgeons are underrepresented as leaders of clinical trials in the United States for several vascular conditions germane to our specialty. Clinical trials registered in the United States were reviewed using the <span>ClinicalTrials.gov</span><svg><path></path></svg> website for several index vascular conditions: abdominal aortic aneurysm, carotid artery disease, hemodialysis access, venous thrombectomy and stenting, and peripheral arterial disease. The specialty and presenting gender of national and site principal investigators were recorded. The gender distribution was compared for trials led by vascular surgeons and nonvascular surgeon physicians. A subgroup analysis was performed for solo and group investigators, intervention types, sponsorship sources, and professional affiliation. Temporal trends were examined to evaluate the relationship between the duration of board certification and clinical trial leadership involvement. For all conditions, female vascular surgeons represent 10.3% and 7.8% of national and site principal investigators, respectively. A significantly lower proportion of female investigators were included in national vascular surgeon-led trials compared with nonvascular surgeon-led trials (10.3% vs 19.9%; <em>P</em> = .006). However, site investigators had a lower, but similar, proportion of women in both groups (7.8% vs 7.9%; <em>P</em> = .89). A significantly lower proportion of female vascular surgeons led clinical trials focused on interventions vs noninterventions (6% vs 11%; <em>P</em> = .02). There was a trend toward fewer female vascular surgeons conducting industry-sponsored trials for group (8% vs 11%; <em>P</em> = .3) and solo (5% vs 12%; <em>P</em> = .1) investigator-led trials. A similar proportion of female investigators had both academic and nonacademic affiliations (15% vs 16%; <em>P</em> = .83). Of 109 individual vascular surgeon investigators who were board certified between 1983 and 2003, 6 were women (5.5%) compared with 24 women (28.6%) of 84 investigators who had received board certification between 2004 and 2023. Finally, female vascular surgeon investigators started leading clinical trials sooner after board certification compared with male investigators (mean, 5.5 years vs 10.9 years; <em>P</em> = .0009). The representation of female leaders in vascular clinical trials lags behind that of male leaders, although this trend has improved over time. However, a percentage of women in vascular surgery are successful in leading clinical trials early in their career, suggesting the importance of strong sponsorship and allyship. Furthermore, it is a call to action to our leaders and our industry partners to “lift the curtain” on the pathway to clinical trial leadership.</p></di","PeriodicalId":74034,"journal":{"name":"JVS-vascular insights","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2949912724000254/pdfft?md5=36d5817ddc4ae0380ca201261a805f97&pid=1-s2.0-S2949912724000254-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140767030","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}